Please login to the form below

Not currently logged in
Email:
Password:

Microbiome

This page shows the latest Microbiome news and features for those working in and with pharma, biotech and healthcare.

Seres’ microbiome-based therapy hits the mark in phase 3

Seres’ microbiome-based therapy hits the mark in phase 3

Drug reduced C.difficile infection recurrence. Seres Therapeutics has reported positive topline data from a phase 3 trail of its microbiome therapy SER-109 for recurrent C.difficile infections. ... SER-109 is an oral, biologically-derived microbiome

Latest news

More from news
Approximately 7 fully matching, plus 10 partially matching documents found.

Latest Intelligence

  • Gut instincts lead Takeda to GI pipeline success Gut instincts lead Takeda to GI pipeline success

    Takeda’s strategy is to develop GI products that address the highest unmet needs, which includes projects across three novel platforms – gene therapy, microbiome and cell therapy.

  • A snapshot of Microbiotica A snapshot of Microbiotica

    How is Microbiotica advancing life sciences with its technology? Microbiotica is a leading expert in the microbiome and is using its technology to identify the good and bad microbiomes in patients. ... There is also a $534m collaboration with Roche’s

  • Pharma’s coral reef Pharma’s coral reef

    If you need another example, look in the mirror and consider that a large part of the creature facing you is made of other organisms, such as those in your microbiome.

  • Deal Watch November 2016 Deal Watch November 2016

    immuno-oncology collaboration based on Enterome's microbiome technology.

  • Building the Future Building the Future

    The human microbiome is an example of this but a coral reef is a better one.

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

  • Former Genzyme group vice president joins Vedanta Biosciences Former Genzyme group vice president joins Vedanta Biosciences

    His experience and leadership in pioneering new drug modalities will be invaluable as we advance our pipeline of microbiome-modulating therapies.”. ... Dr Roberts said: “Microbiome modulation is among the most exciting and rapidly evolving fields in

  • Vedanta Biosciences appoints two new heads Vedanta Biosciences appoints two new heads

    Vedanta is advancing a pipeline of product candidates designed to treat autoimmune, inflammatory and infectious diseases using technology that mines the human microbiome for potent pharmaceutical products.

  • Ritter Pharmaceuticals appoints new CMO Ritter Pharmaceuticals appoints new CMO

    Ritter is currently developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. ... microbiome. “I believe my experience in product development coupled with my research capabilities will be a great

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....

Infographics